E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 11/12/2019 in the Prospect News Investment Grade Daily.

Post-holiday preferreds mixed; Fortress Biotech, Goldman Sachs, American Equity offer deals

By Cristal Cody

Tupelo, Miss., Nov. 12 – Preferred stock indexes ended Tuesday moderately better with several issuers announcing deals.

The Wells Fargo Hybrid and Preferred Securities index was up 0.1% over the morning and closed the day 0.22% better.

The U.S. iShares Preferred Stock ETF rose 10 cents or 0.29%, early Tuesday and ended the session up 11 cents, or 0.3%, at $37.07.

In the primary market, Fortress Biotech, Inc. announced plans to price a registered add-on to its 9.375% $25-par series A perpetual preferred stock.

The preferreds, traded under the symbol “FBIOP” on the Nasdaq Capital Market, closed the day down 15 cents, or 0.73%, at $20.89 on trading volume of about 5,000 shares.

At the start of the day, the Fortress Biotech preferreds fell 6 cents.

The securities were last reported on Monday at $21.04 a share.

Meanwhile, Goldman Sachs Group Inc. launched an offering of depositary shares on Tuesday.

Also, American Equity Investment Life Holding Co. marketed a registered offering of $25-par depositary shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.